Dr. Barbara Lomeli

Dr Lomeli received her Medical Degree (MD) from the University of Kansas, Internship in Internal Medicine at the University of Iowa, and Residency in Emergency Medicine at the UMKC School of Medicine in Kansas City.

Dr. Stephen Flach

Stephen Flach, Md, PhD, is a board-certified internist who has worked in Clinical Pharmacology since 2005 as a Principal Investigator, Medical Monitor, and Consultant on a wide range of early phase drug development projects.

Impairment Studies for Clinical Development

Meeting aggressive data delivery timelines in one of the first‑ever CAR‑T studies with pediatric and adolescent patients

Increasing engagement and collaborative practices in two Phase III oncology trials

Agility and flexibility are key in delivering tandem mega oncology trials in a highly complex clinical trial landscape

Ophthalmology gene therapy trial: Insights from a Senior Clinical Project Manager

At Fortrea, we recognize that the deep knowledge and leadership of our diversity teams are fundamental to driving innovation and delivering results for our sponsors

Biopharma

Proactively recognizing and managing trial risks with Xcellerate® Central Monitoring

How can clinical study teams use an AI-powered centralized monitoring solution to help detect risk earlier and maintain timelines?

Simplifying and accelerating risk identification and assessment with Xcellerate® Central Monitoring

How can a real-time, AI powered central monitoring solution improve data integrity, streamline decision-making and proactively manage trial quality?